Cordero A A, Guglielmi H A, Woscoff A
Cutis. 1980 Sep;26(3):319-20, 322, 324.
Thirty-six patients were treated for single or multiple warts by intralesional injection of bleomycin sulfate (Blenoxane) at the base of the wart. The dose varied according to the size of the lesion and ranged from 0.2 to 0.8 mg per injection, up to a maximum total dose of 2 mg. The cure rates were as follows: 67 percent in plantar warts; 82 percent in ungual warts; and 80 percent in warts located elsewhere. The cure rate for all patients was 75 percent. The drug was well tolerated and the procedure readily accepted by the patients.
36例患者因单个或多个疣，通过在疣体基部病灶内注射硫酸博来霉素（争光霉素）进行治疗。剂量根据病灶大小而有所不同，每次注射剂量为0.2至0.8毫克，最大总剂量为2毫克。治愈率如下：跖疣为67%；甲周疣为82%；其他部位的疣为80%。所有患者的治愈率为75%。该药物耐受性良好，患者对该治疗方法也易于接受。
